THE BETAMI-DANBLOCK TRIAL: RANDOMIZED DISCONTINUATION OF BETA-BLOCKERS AFTER MYOCARDIAL INFARCTION

30 August 2025 (11:10 - 11:20)
Organised by: Logo
Congress Presentation Part of: HOT LINE 3 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by